Search results
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Tempest (TPST) Up as First-Line Liver Cancer Study Meets Goals
Zacks via Yahoo Finance· 8 months agoTempest (TPST) skyrockets 2879% on positive new and updated findings from its early-mid-stage study...
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo Finance· 1 week agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...